On Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse Eli Lillys drug donanemab, a monoclonal antibody designed to slow the progression of early symptomat… [read more]
Blog
On Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse Eli Lillys drug donanemab, a monoclonal antibody designed to slow the progression of early symptomat… [read more]
